Studies have found that overexpression of TPM2 increases the production of HBV, and in HBV-related HCC or acute liver failure, TPM2 expression increases about 4-fold to over 6-fold, respectively [34,35]. Here, TPM2 is linked to hepatocellular carcinoma.